Search Clinical Trials
Recruiting
Fetal Endotracheal Occlusion (FETO) in the Resolution of Pulmonary Hypertension in Fetuses With Severe CDH (External Link)
Enrollment Women carrying a fetus with severe CDH and a normal karyotype will undergo routine clinical evaluation. The fetus will be 28+0/7 to 31+6/7 weeks of gestational age and have …
Baylor Role:
Collaborator
Recruiting
Accessing Mobility Using Wearable Sensors (External Link)
The investigators specific research questions: (1) Which motor-cognitive parameters measurable by wearable sensors (e.g. gait, balance, frailty index, etc) are linked to specific diseases (e.g. COPD, CHF) (2) Which motor-cognitive …
Baylor Role:
Lead Sponsor
Recruiting
Effects of Transitional Circulation in ELBW Infants (External Link)
Screening Phase: The subject's parents/guardians/LAR will be approached if the infant's birth weight makes them eligible for this research study. Study Phase: During this study, we will use the monitoring …
Baylor Role:
Lead Sponsor
Recruiting
EO2 Oxygen Delivery To Study Success Rate of Surgically Closed Wounds (External Link)
Surgical wound (e.g., post minor amputation, reconstruction surgery, or surgical incision) complications such as infection, dehiscence, necrotic tissue, surgical revision, and poor cosmesis are unfortunately highly prevalent in patients undergoing …
Baylor Role:
Lead Sponsor
Recruiting
Prediction of Brain Injury in Premature Infants (External Link)
This is a prospective, single-center, data collection research study for premature ELBW infants at high risk of developing brain injury. This study is being done to evaluate the changes in …
Baylor Role:
Lead Sponsor
Recruiting
Investigation of the Genetics of Hematologic Diseases (External Link)
Participants will be individuals (proband) receiving therapy or expert consultation regarding a non-malignant hematologic disorder. We propose to use genomics, transcriptomics, proteomics and metabolomic analysis coupled with family linkage studies …
Baylor Role:
Collaborator
Recruiting
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma (External Link)
Up to 390 mL (78 teaspoons) of blood will be collected from the patient on one to three occasions over a two month period. Under certain conditions related to the …
Baylor Role:
Lead Sponsor
Recruiting
Long-term Outcomes and Vascular Evaluation After Coarctation of the Aorta Treatment (External Link)
Study overview. This cross-sectional prospective observational study of patients with CoA previously treated using one of three treatment modalities assesses if treatment type is associated with differences in vascular function. …
Baylor Role:
Collaborator
Recruiting
Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL (External Link)
To prepare the lymphoma, MM or CLL specific T cells investigators will take 240 ml (up to 16 tablespoonfuls)of blood from the patient. This would be drawn as 2 (two) …
Baylor Role:
Lead Sponsor